Patents by Inventor Surendra Mehta

Surendra Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LAMOTRIGINE SUSPENSION DOSAGE FORM
    Publication number: 20200046716
    Abstract: The present invention relates to a stable ready to use and powder for oral suspension dosage forms of Lamotrigine and its pharmaceutically acceptable salts and process of preparing such compositions. The liquid and powder for oral suspension dosage forms of Lamotrigine have been previously known only as extemporaneous preparations. Present invention relates to manufacture of liquid and powder for oral suspension dosage forms of Lamotrigine having improved physico-chemical properties with desired technical attributes. The prepared dosage forms are useful in patients having difficulties in swallowing tablets and provide physician with more options for dose titration.
    Type: Application
    Filed: February 2, 2018
    Publication date: February 13, 2020
    Inventors: Kamal Surendra Mehta, Dinesh Kumar, Saurabh Srivastava, Amit Jha, Rakesh K. Singh
  • Process for preparing an ultra-pure thrombin preparation
    Patent number: 5525498
    Abstract: An ultra-pure, clear thrombin solution having a high specific activity is described as well as a method of manufacture.
    Type: Grant
    Filed: February 22, 1991
    Date of Patent: June 11, 1996
    Assignee: Warner-Lambert Company
    Inventors: Amal Boctor, Surendra Mehta, Galen Radebaugh
  • Ultra-pure thrombin preparation
    Patent number: 5397704
    Abstract: An ultra-pure, clear thrombin solution having a high specific activity is described as well as a method of manufacture.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: March 14, 1995
    Assignee: Warner-Lambert Company
    Inventors: Amal Boctor, Surendra Mehta, Galen Radebaugh
  • Process for purified thromboplastin for ultra-pure thrombin preparation
    Patent number: 5281528
    Abstract: A process for the manufacture of purified thromboplastin used in the manufacture of an ultra-pure, clear thrombin solution is described.
    Type: Grant
    Filed: November 6, 1992
    Date of Patent: January 25, 1994
    Assignee: Warner-Lambert Company
    Inventors: Amal Boctor, Surendra Mehta, Galen Radebaugh